| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/17/2005 | CA2547933A1 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor |
| 11/16/2005 | EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides |
| 11/16/2005 | EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies |
| 11/16/2005 | EP1595949A1 Method of degrading plastic and process for producing useful substance using the same |
| 11/16/2005 | EP1595947A1 MN gene and protein |
| 11/16/2005 | EP1595891A1 Preparing albumin protein conjugated oligonucleotide probes |
| 11/16/2005 | EP1595890A2 Synthetic peptide inhibitors of HIV transmission |
| 11/16/2005 | EP1595548A2 Anti-neovasculature preparations for treating cancer |
| 11/16/2005 | EP1595547A2 Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure |
| 11/16/2005 | EP1595145A2 Methods for the treatment of renal cell carcinoma |
| 11/16/2005 | EP1594989A2 Methods for the early diagnosis of ovarian cancer |
| 11/16/2005 | EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof |
| 11/16/2005 | EP1594966A2 Delta-endotoxin genes and methods for their use |
| 11/16/2005 | EP1594965A2 Fusion proteins of interferon alpha muteins with improved properties |
| 11/16/2005 | EP1594956A2 System for expression of genes in plants |
| 11/16/2005 | EP1594898A2 Glycosylated specificity exchangers |
| 11/16/2005 | EP1594895A1 Growth factor complexes and modulation of cell migration and growth |
| 11/16/2005 | EP1594894A2 Mtor kinase-associated proteins |
| 11/16/2005 | EP1594893A2 Therapeutic targets in cancer |
| 11/16/2005 | EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 11/16/2005 | EP1594891A1 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 11/16/2005 | EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 11/16/2005 | EP1594561A2 Yersinia species compositions |
| 11/16/2005 | EP1594560A2 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 11/16/2005 | EP1594549A2 Hypoxia inducible vegf plasmid for ischemic disease |
| 11/16/2005 | EP1594539A2 Compositions for modulating immune cell activity and methods for detection thereof |
| 11/16/2005 | EP1594538A2 Composition to be administered to a living being and method for marking agents |
| 11/16/2005 | EP1594533A2 Antibody vaccine conjugates and uses therefor |
| 11/16/2005 | EP1594532A2 Methods and compositions for the inhibition of cathepsins |
| 11/16/2005 | EP1594530A2 Albumin fusion proteins |
| 11/16/2005 | EP1594529A2 Analogues of glp-1 |
| 11/16/2005 | EP1594525A1 Regulation of allergen induced gene |
| 11/16/2005 | EP1594518A2 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 11/16/2005 | EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 11/16/2005 | EP1594469A1 Peptidic nanoparticles as drug delivery and antigen display systems |
| 11/16/2005 | EP1594447A2 Compositions and methods for the diagnosis and treatment of tumor |
| 11/16/2005 | EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 11/16/2005 | EP1594444A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 11/16/2005 | EP1594437A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 11/16/2005 | EP1594436A2 Polymer conjugates of mutated neublastin |
| 11/16/2005 | EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 11/16/2005 | EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 11/16/2005 | EP1531664A4 Genes encoding proteins with pesticidal activity |
| 11/16/2005 | EP1506223B1 Fusion protein of hiv regulatory/accessory proteins |
| 11/16/2005 | EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 11/16/2005 | EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha |
| 11/16/2005 | EP1463823A4 Methods of increasing endogenous erythropoietin (epo) |
| 11/16/2005 | EP1358315A4 Identification of an advanced sleep phase syndrome gene in humans |
| 11/16/2005 | EP1322786A4 Method of identifying putative antibiotic resistance genes |
| 11/16/2005 | EP1315805B1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 11/16/2005 | EP1309338B1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer |
| 11/16/2005 | EP1263458B1 Lowering serum cholesterol |
| 11/16/2005 | EP1213353B1 Peptide leukotriene receptor |
| 11/16/2005 | EP1206550B1 Proteins derived from white spot syndrome virus and uses thereof |
| 11/16/2005 | EP1196450B1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 11/16/2005 | EP1109823B1 Modifications of the vegf receptor-2 protein and methods of use |
| 11/16/2005 | EP1082423B1 Cyclin e2 genes and proteins |
| 11/16/2005 | EP1068328B1 Treatment and diagnosis of staphylococcal infections |
| 11/16/2005 | EP1062235B1 A method for isolating and purifying soluble proteins and peptides from plant sources |
| 11/16/2005 | EP1049479B1 Analgesic from snake venom |
| 11/16/2005 | EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 11/16/2005 | EP0909322B1 Antiviral ricin-like proteins |
| 11/16/2005 | EP0873406B1 Protein induced by deprenyl |
| 11/16/2005 | EP0871703B1 Dna encoding glutamate gated chloride channels |
| 11/16/2005 | EP0851868B1 High level expression of green fluorescent protein |
| 11/16/2005 | EP0832232B1 Kunitz type plasma kallikrein inhibitors |
| 11/16/2005 | EP0788547B1 Purified coprinus laccases and nucleic acids encoding same |
| 11/16/2005 | EP0749491B1 Enhanced expression in a plant plastid |
| 11/16/2005 | EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
| 11/16/2005 | EP0741745B1 Hepatitis b vaccine |
| 11/16/2005 | EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof |
| 11/16/2005 | EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 11/16/2005 | EP0477295B2 Platelet aggregation inhibitors |
| 11/16/2005 | CN1697973A Immunoassay |
| 11/16/2005 | CN1697878A Novel peptides having cAMP producing activity |
| 11/16/2005 | CN1697792A Improved extraction process |
| 11/16/2005 | CN1696301A Process for clavulanic acid production by microbial thallus |
| 11/16/2005 | CN1696293A Gene recombined chemotaxis antigen vaccine |
| 11/16/2005 | CN1696156A Method for purifying Sa antigen |
| 11/16/2005 | CN1696155A Gene of restraining activation NF-kB and NFAT, and coded polypeptide |
| 11/16/2005 | CN1696154A Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 11/16/2005 | CN1696153A Harpineccs protein of Erwinia aroideae, complexation of relevant proteins and application |
| 11/16/2005 | CN1696152A LIE7 recombined protein of 16 type human papilomavirus expressed by bacillus coli |
| 11/16/2005 | CN1227362C Biosynthetic genes for spinosyn insecticide production |
| 11/16/2005 | CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 11/16/2005 | CN1227359C Down-regualtion resistant C3 convertase |
| 11/16/2005 | CN1227265C Antibodies to CCR5 |
| 11/16/2005 | CN1227264C Immunogenic peptides derived from MAGE and use thereof |
| 11/16/2005 | CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases |
| 11/16/2005 | CN1227262C Protein related to plant cell cycle and its coding gene |
| 11/16/2005 | CN1227032C Vaccines with an LTB adjuvant |
| 11/16/2005 | CN1227027C Novel compositions |
| 11/15/2005 | US6965850 Methods for modulating nuclear receptor coactivator binding |
| 11/15/2005 | US6965063 Genetic engineering; insect and herbicide resistant corn |
| 11/15/2005 | US6965060 Production of silk-like proteins in plants |
| 11/15/2005 | US6965024 Reactive with ganglioside GD3; cancer treatment |
| 11/15/2005 | US6965023 Death domain proteins |
| 11/15/2005 | US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |
| 11/15/2005 | US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods |